![Marcio Scorsin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Marcio Scorsin
Società | Posizione | Inizio | Fine |
---|---|---|---|
MYOSIX SA
![]() MYOSIX SA BiotechnologyHealth Technology MYOSIX SA develops cell-based therapeutics. The company is involved in the development of autologous cell therapy products for the treatment of cardiopathies and certain forms of myopathy in humans. MYOSIX specializes in the development of cell-based therapeutics against other pathologies like cancers. MYOSIX is also engaged in a number of R&D projects and develops a cell and tissue bank for therapeutic or R&D purposes. The company was founded by Vilquin, Marolleau, Scorsin, Eisenmann and Halioua in 2000 and is headquartered in Saint-Germain-en-Laye, France. | Corporate Officer/Principal | 01/09/2000 | - |
Epygon SASU
![]() Epygon SASU Medical SpecialtiesHealth Technology Epygon SASU develops mitral valve instruments. It also engages in the research and development in physical and natural sciences. The company was founded by Marcio Scorsin and Enrico Pasquino on December 28, 2011 and is headquartered in Paris, France. | Fondatore | 28/12/2011 | - |
Corporate Officer/Principal | 28/12/2011 | - |
Storia della carriera di Marcio Scorsin
Precedenti posizioni note di Marcio Scorsin
Società | Posizione | Inizio | Fine |
---|---|---|---|
AFFLUENT MEDICAL | Direttore Tecnico/Scientifico/R&S | - | - |
Statistiche
Distribuzione geografica
Francia | 4 |
Posizioni
Corporate Officer/Principal | 2 |
Founder | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
AFFLUENT MEDICAL | Health Technology |
Aziende private | 2 |
---|---|
MYOSIX SA
![]() MYOSIX SA BiotechnologyHealth Technology MYOSIX SA develops cell-based therapeutics. The company is involved in the development of autologous cell therapy products for the treatment of cardiopathies and certain forms of myopathy in humans. MYOSIX specializes in the development of cell-based therapeutics against other pathologies like cancers. MYOSIX is also engaged in a number of R&D projects and develops a cell and tissue bank for therapeutic or R&D purposes. The company was founded by Vilquin, Marolleau, Scorsin, Eisenmann and Halioua in 2000 and is headquartered in Saint-Germain-en-Laye, France. | Health Technology |
Epygon SASU
![]() Epygon SASU Medical SpecialtiesHealth Technology Epygon SASU develops mitral valve instruments. It also engages in the research and development in physical and natural sciences. The company was founded by Marcio Scorsin and Enrico Pasquino on December 28, 2011 and is headquartered in Paris, France. | Health Technology |
- Borsa valori
- Insiders
- Marcio Scorsin
- Esperienza